Leap Therapeutics (LPTX) Reports Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer (PFE) to Evaluate Combination of TRX518, Avelumab, and Chemotherapy
Tweet Send to a Friend
Leap Therapeutics, Inc. (NASDAQ: LPTX) today announced it has entered into a collaboration agreement with Merck KGaA, Darmstadt, Germany, and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
